How Semax and Selank Actually Work for Focus and Anxiety

Your brain used to just work. You could hold five threads at once, switch between tasks without losing your place, and fall asleep without replaying every conversation from the day. Now you're 38 or 43 or 51, and the fog rolled in so gradually you almost didn't notice until you re-read the same paragraph four times or forgot the word for "spatula." This article gives you the full, evidence-graded breakdown on two peptides that women are using right now for exactly this problem, what the data actually supports, what it costs, and how to get them through a provider in 2025.

Key Takeaways

• Semax earns a LOW-MODERATE evidence grade for focus and cognition. It's approved in Russia for cognitive and stroke recovery, with a 110-patient stroke trial showing measurable BDNF increases, but no Western RCTs exist.
• Selank earns a LOW-MODERATE evidence grade for anxiety. Across roughly 192 patients in Russian trials, it matched benzodiazepines for generalized anxiety without sedation or dependence.
• Typical cost for compounded Semax nasal spray runs $60–$120/month (2025 pricing). Selank is harder to access in the US after its compounding nomination was withdrawn in September 2024.
• Both are intranasal peptides, not pills, not injections. Onset is fast: women commonly report noticing Semax within 15–30 minutes and Selank within 20–40 minutes.
• They aren't interchangeable. Semax is the focus and neuroprotection peptide. Selank is the anxiolytic. Many women stack both.
• If perimenopause brain fog is your primary issue, combining either peptide with HRT (where indicated) is the protocol women report the most dramatic results from.

---

Why Women Are Reaching for Peptides Instead of SSRIs and Adderall

Here's the conversation that keeps happening: you tell your doctor you can't think straight, you're anxious in a way that feels physical, and your sleep is wrecked. You get offered an SSRI (which may flatten your affect and tank your libido for months before "maybe" helping), buspirone (which takes 4–6 weeks to kick in, if it does), or a stimulant prescription that makes you feel wired but not actually clear. If you're in perimenopause, there's a solid chance the doctor doesn't connect your cognitive symptoms to hormonal shifts at all.

So you start looking. And you find Semax and Selank.

These aren't new compounds. They were developed at the Institute of Molecular Genetics at the Russian Academy of Sciences, and Semax has been prescribed in Russia since the early 1990s for stroke recovery and cognitive impairment. Selank received Russian regulatory approval in 2009 as an anxiolytic. The reason most American women haven't heard of them is simple: no pharmaceutical company has funded the Western trials that would put them on your PCP's radar.

That gap between "approved and prescribed in another country for decades" and "invisible to your doctor" is exactly where the interesting conversation lives. Women on these protocols aren't waiting for a Phase III trial at Johns Hopkins. They're reporting results now, and the mechanistic science backing those reports is genuinely compelling.

---

What Semax and Selank Actually Do in Your Brain

These two peptides get lumped together constantly, but they work through completely different pathways and solve different problems. Think of them as complementary tools, not interchangeable options.

Semax: The Focus and Neuroprotection Peptide

Semax is a synthetic analog of ACTH(4-10), a fragment of the hormone your pituitary gland makes. Its headline mechanism is BDNF upregulation. BDNF (brain-derived neurotrophic factor) is the protein your neurons need to grow, strengthen connections, and survive stress. It's the single most important molecule in neuroplasticity, the brain's ability to rewire and adapt.

In rat hippocampus studies (Dolotov et al., 2006), a single intranasal dose of Semax produced a 1.4-fold increase in BDNF protein levels, a 3-fold increase in exon III BDNF mRNA, and a 1.6-fold increase in TrkB receptor phosphorylation (the receptor BDNF actually binds to). The animals showed measurable improvements in conditioned avoidance tasks, a standard cognitive performance test.

Beyond BDNF, Semax modulates dopamine and serotonin systems, which is why women describe the effect as "clean focus" rather than stimulant-style tunnel vision. It also has documented neuroprotective properties. In a clinical trial of 110 ischemic stroke patients, intranasal Semax administered as two 10-day courses at 6,000 mcg/day produced measurable increases in plasma BDNF.

Translation for your actual life: Semax supports the biological machinery your brain uses to stay sharp, form memories, and recover from insult. It doesn't force alertness the way a stimulant does. It feeds the system.

Selank: The Calm-Without-Sedation Peptide

Selank is a synthetic analog of tuftsin, a naturally occurring immune peptide. Its primary mechanism is GABAergic modulation, meaning it influences the same inhibitory neurotransmitter system that benzodiazepines target, but through a different, gentler pathway.

Where benzos slam the GABA-A receptor like a sledgehammer (producing sedation, dependence, and cognitive impairment), Selank works upstream. It modulates the balance of inhibitory and excitatory signaling, and it inhibits enzymes that break down enkephalins (your body's natural calming peptides). There's also documented immune-neuro crosstalk, meaning Selank appears to reduce neuroinflammation, which is increasingly linked to anxiety and mood disorders.

The clinical result, as reported in Russian trials: anxiety reduction comparable to benzodiazepines, with no sedation, no cognitive impairment, no dependence, and no withdrawal syndrome.

Translation: Selank quiets the noise without turning down the volume on everything else. The rumination loop slows. The physical anxiety (chest tightness, restlessness, that 3 AM cortisol spike) softens. But you stay sharp.

---

Semax vs Selank: Evidence Grades for Focus, Anxiety, and Brain Fog

Let's be direct about what we know and what we're extrapolating. Like most research peptides, neither Semax nor Selank is FDA-approved in the United States, which is exactly why the interesting real-world evidence lives in what women are actually reporting and what the Russian clinical data shows. The Russian regulatory system reviewed these compounds and approved them, and the trials that supported those approvals are real, peer-reviewed, and indexed on PubMed. They're also small, conducted by researchers affiliated with the development teams, and have never been independently replicated by Western groups.

That doesn't make the data fake. It means you should weight it appropriately.

How to read these grades: MODERATE means human trial data exists with a plausible mechanism, but sample sizes are small and all from one research ecosystem. LOW-MODERATE means limited human data supported by strong mechanistic evidence and consistent anecdotal reports. LOW means mechanism-plus-anecdote only, or the compound wasn't studied for that specific use.

The honest summary: Semax has the strongest case for neuroprotection and cognitive support. Selank has the strongest case for anxiety. Neither has been studied in the specific population that's probably reading this (perimenopausal women with brain fog who are otherwise healthy). The mechanism is right. The early data points in the right direction. The community reports are remarkably consistent. But the large, independent, Western RCT doesn't exist yet.

---

What Women Actually Report: Focus, Calm, and the Placebo Question

Community experience with these peptides is extensive and strikingly consistent across forums, provider reports, and women's health groups. That consistency matters, even though it's not the same as blinded trial data.

• Noticeably sharper task-switching within the first 1–2 days of use
• A "lights on" feeling, described less like stimulant alertness and more like the fog simply lifting
• Improved verbal fluency (finding words faster, clearer articulation in meetings)
• Effects that build over a 2–3 week course, with the most pronounced improvements around days 10–14
• A sustained "afterglow" of improved cognition for 1–3 weeks after stopping a cycle

• Reduced rumination within 20–40 minutes of the first dose
• Physical anxiety symptoms (tight chest, shallow breathing, jaw clenching) softening noticeably within the first week
• Better sleep onset, not from sedation, but from the absence of the racing-thoughts loop
• No emotional blunting (the number one complaint about SSRIs)
• Clearer mornings, especially when stacked with Semax

The placebo question is real and worth naming. When you're doing something proactive about a problem that's been making you miserable, the act itself can produce improvement. Unblinded self-experimentation is vulnerable to confirmation bias. Some of what women report may be placebo. But the mechanistic data (BDNF upregulation, GABAergic modulation, enkephalin preservation) provides a biological basis for exactly the effects being described. And the consistency of reports across thousands of users, including specific timelines and dose-response patterns, goes beyond what you'd typically see from pure placebo.

---

Dosing Protocols: How Semax and Selank Are Actually Used

Both peptides are administered intranasally. This isn't a pill you swallow or a shot you inject. It's a calibrated nasal spray, typically one or two sprays per nostril, done in the morning (Semax) or as needed (Selank). The intranasal route matters because it bypasses first-pass liver metabolism and delivers the peptide closer to the brain via the olfactory and trigeminal nerve pathways.

On stacking: Running Semax and Selank together is extremely common in the community and mirrors how they were studied together in Russian research on enkephalin-degrading enzyme inhibition. The logic is straightforward: one addresses focus and neuroprotection, the other addresses anxiety and calm. They work through different pathways and don't compete.

On dose-response: Honest disclosure here. Systematic dose-finding studies with modern pharmacokinetic methods don't exist for either peptide. The dosing ranges above come from Russian clinical protocols and extensive community use. Most women start at the lower end (200 mcg/day) and titrate up based on response. Your provider should help you find the right dose.

A note on contraindications: If you're on MAOIs or other medications that significantly affect serotonin or dopamine metabolism, discuss Semax with your provider before starting. Selank's interaction profile is minimal based on available data, but anyone on benzodiazepines should coordinate tapering/transition with a prescriber. Both peptides appear to have minimal side effects in clinical data and community reports. The most commonly noted effects are mild nasal irritation and, with Semax, occasional headache at higher doses.

---

Regulatory Status and How to Actually Get Them in 2025

This is where the two peptides diverge significantly, and it matters for your access plan.

Semax is currently available through 503A compounding pharmacies in the United States. A 503A pharmacy compounds medications on an individual-patient basis with a valid prescription. You need a provider (physician, NP, or PA) to write the script, and the pharmacy compounds your nasal spray. This is a legitimate, legal pathway. Multiple peptide-literate telehealth providers and integrative medicine clinics prescribe compounded Semax right now.

Selank is a different story. Its category-two compounding nomination was withdrawn in September 2024, and no PCAC (Pharmacy Compounding Advisory Committee) review is currently scheduled. This means there is no active 503A compounding pathway for Selank in the United States as of early 2025. Some women access it through international providers or clinics outside the US. If Selank is your primary interest, you'll want to discuss current availability directly with a peptide-literate provider who can advise on your specific options.

What kind of provider to look for: You want a physician, NP, or PA who specifically works with peptide protocols. Integrative medicine, functional medicine, and anti-aging/regenerative medicine clinics are the most likely to have experience with Semax and Selank. Peptide-focused telehealth platforms are another route. When you book a consultation, a good provider will ask about your current medications, hormonal status (especially if you're perimenopausal), thyroid function, and what you've already tried for your symptoms. That conversation is how they determine whether Semax, Selank, or a different approach makes sense for you.

---

What Semax and Selank Cost Compared to Conventional Options

You're probably already spending money on something for focus or anxiety. Here's the real math.

The trade-off is transparent. SSRIs and stimulants have stronger evidence grades because they've been through massive Western trials. They also carry significantly heavier side-effect profiles. Semax and Selank have lighter evidence but dramatically fewer reported side effects. For a woman who's tried an SSRI and hated how it made her feel, or who doesn't want to go the stimulant route, the risk-benefit math looks different than it does on paper for a regulatory agency.

And if you're spending $200/month on supplements, adaptogens, and nootropic stacks from Instagram ads with zero clinical evidence behind them, redirecting that budget to a compounded peptide with actual mechanism data and decades of clinical use in another country is arguably the more rational move.

---

Your Route Map: Which Peptide, Which Provider, What Order

If your primary issue is focus and brain fog: Start with Semax. It's the more accessible option in 2025 (legal 503A compounding pathway), the mechanism directly addresses cognitive performance via BDNF, and the onset is fast enough that you'll know within 1–2 weeks whether it's working for you. Typical first protocol: 200–400 mcg/day intranasally for 14–21 days, then assess.

If your primary issue is anxiety and rumination: Selank is the more targeted compound, but access is currently limited in the US. Talk to a peptide-literate provider about current availability. If Selank isn't accessible, Semax still has some anxiolytic properties via serotonin modulation, and your provider may suggest alternatives like magnesium threonate or specific GABAergic compounds while monitoring the regulatory landscape.

If you have both (and honestly, most women reading this do): The Semax + Selank stack is the protocol women report the most comprehensive results from. Semax in the morning for focus, Selank as needed or in the afternoon/evening for calm. Your provider can help sequence the introduction (most start with one for a week, then add the second).

If you're in perimenopause: This is the critical piece most peptide discussions miss. If your brain fog and anxiety arrived alongside irregular cycles, night sweats, or other hormonal shifts, peptides alone may be treating downstream symptoms while the upstream cause (declining estradiol and progesterone) goes unaddressed. Estradiol is directly neuroprotective and supports BDNF expression. Progesterone metabolites (specifically allopregnanolone) are potent GABA-A receptor modulators, the same system Selank influences.

The women who report the most dramatic cognitive and mood improvements are typically the ones combining peptides with properly dosed HRT. Semax + HRT for brain fog. Selank + HRT for anxiety. The peptides and the hormones work through complementary pathways.

Your next move: If you're not sure whether focus, anxiety, energy, or something else should be your starting point, build your personal plan to see which protocols match your symptoms and goals.

---

Frequently Asked Questions

Do Semax and Selank actually work or is this all Russian data hype?

The data is real, peer-reviewed, and indexed on PubMed. Semax has been prescribed in Russia since the early 1990s. Selank completed Phase III trials and received Russian regulatory approval in 2009. The limitation is that all human data comes from Russian-affiliated research groups with relatively small sample sizes (110 patients for the Semax stroke trial, ~192 patients across Selank anxiety trials), and no independent Western group has replicated the findings. That's a legitimate reason to grade the evidence as LOW-MODERATE rather than STRONG. It's not a reason to dismiss compounds with decades of clinical use and consistent mechanistic data.

Can I take Semax and Selank together?

Yes, and most women who use both do exactly that. They work through different mechanisms (BDNF/dopamine for Semax, GABA/enkephalin for Selank) and were studied together in Russian research. The common protocol is Semax in the morning, Selank in the afternoon or evening. Your provider can help you sequence the introduction.

Is Selank still legal to get in the US after the 2024 compounding change?

As of early 2025, Selank's category-two compounding nomination was withdrawn in September 2024, and no PCAC review is scheduled. This means there's no active 503A compounding pathway in the US. Some women access it through international clinics or providers with alternative sourcing. A peptide-literate provider is your best resource for current options.

How fast do Semax and Selank kick in?

Semax: most women notice acute effects within 15–30 minutes of intranasal administration. The cumulative, "this is a different brain" effect typically builds over 7–14 days of consistent use. Selank: acute anxiolytic effects within 20–40 minutes. Full benefit at 7–14 days. Both are notably faster than SSRIs (4–8 weeks) or buspirone (4–6 weeks).

Are there side effects I should worry about with Semax or Selank?

Across all available clinical data and extensive community use, the side-effect profile for both peptides is remarkably clean. The most commonly reported effects are mild nasal irritation (it's a nasal spray) and occasional headache with Semax at higher doses. Selank's Russian prescribing information states "no noted side effects" across ~192 clinical subjects. The caveat: no GLP toxicology study by Western standards exists for either compound, and long-term safety data beyond the Russian clinical experience is limited. If you're on MAOIs or medications affecting serotonin/dopamine metabolism, discuss Semax with your provider. If you're on benzodiazepines, coordinate any Selank use with your prescriber.

Will Semax or Selank help with perimenopause brain fog specifically?

Neither has been directly studied in perimenopausal women. However, the mechanisms are highly relevant. Perimenopause brain fog is driven partly by declining estradiol (which supports BDNF expression and synaptic plasticity) and progesterone (whose metabolites modulate GABA). Semax directly upregulates BDNF. Selank directly modulates GABA. Women in perimenopause who combine these peptides with HRT report the most significant improvements, likely because you're addressing both the hormonal root cause and the downstream neurochemical effects.

How do Semax and Selank compare to modafinil or Adderall for focus?

Different tools entirely. Modafinil and Adderall are wakefulness-promoting agents and stimulants, respectively. They force alertness through dopamine and norepinephrine. Semax supports cognitive infrastructure (BDNF, synaptic plasticity) rather than overriding fatigue signals. Women who've tried both typically describe stimulants as "wired but not clear" and Semax as "the fog lifts." Stimulants have stronger evidence grades (large Western RCTs) but heavier side-effect profiles (insomnia, appetite suppression, cardiovascular strain, dependence risk with Adderall). Semax has a lighter evidence base but a dramatically cleaner side-effect profile.

Do I need a prescription for Semax or Selank?

For compounded Semax through a 503A pharmacy in the US, yes, you need a prescription from a licensed provider (MD, DO, NP, or PA). Peptide-literate telehealth providers and integrative medicine clinics are the most straightforward route. For Selank, the US compounding pathway is currently unavailable (as of early 2025), so access depends on your provider's recommendations for alternative routes.

What happens when I stop taking Semax or Selank? Is there withdrawal?

No withdrawal syndrome has been reported for either peptide in clinical data or community experience. This is one of the key differentiators from benzodiazepines (which can cause severe withdrawal) and SSRIs (which cause discontinuation syndrome in many users). Women typically report that Semax's cognitive benefits persist for 1–3 weeks after completing a cycle, then gradually fade, which is consistent with the BDNF upregulation mechanism (structural brain changes outlast the peptide's direct presence). Selank's anxiolytic effects tend to fade more quickly after stopping, typically within a few days to a week.

How do I know if my compounding pharmacy is giving me real Semax?

Work with a provider who prescribes through an established 503A compounding pharmacy. Your prescribing provider should be able to tell you which pharmacy they use and why they trust it. That relationship between your provider and their compounding pharmacy is your quality assurance.

Are there other peptides worth considering alongside Semax and Selank?

If energy and metabolic function are part of your picture, MOTS-c for energy targets mitochondrial output through a completely different pathway. Women pursuing a broader recovery protocol sometimes pair cognitive peptides with compounds like BPC-157 and TB-500 for tissue repair, or explore NAD+ for cellular energy as another angle on the fatigue piece. Your provider can help you decide what's worth layering and what's overkill.